Besides survival analyses, univariate and multivariate analyses indicated that expression of HER family members (such as HER2, HER3 and HER2-HER3 co-expression state) as well as p-mTOR significantly decreased the survival of GC patients. This evidence concerns the gene ERBB2 and gastric cancer.